In the latest close session, CRISPR Therapeutics AG (CRSP) was down 3.05% at $66.06. The stock's performance was behind the S&P 500's daily gain of 0.07%. Meanwhile, the Dow lost 0.7%, and the Nasdaq, ...

IBM stock fell late Wednesday despite the tech giant reporting second-quarter results that exceeded expectations.

The ASX slid 0.5pc this morning, as the materials sector continued to show weakness. Energy was up 0.97pc with little other support.